Ellie Lipschultz
Person
Ellie Lipschultz is a financial commentator and guest speaker who analyzes market activity. She has discussed major corporate events, including the merger between On Semi and Synaptics, providing insights into stock movements and arbitrage.
What Ellie Lipschultz has said on podcasts
4 statements
The acquisition expands On Semiconductor's total addressable market beyond data centers.
“this does expand their TAM as opposed to just really diving deeper into data centers”
Open the episode · Synaptics Rises, Lumentum Falls, Acadia Pharma Jumps on Positive CHMP Drug OpinionListen at 1:45
The Philadelphia Semiconductor Index remains up approximately 91% year to date.
“the SOX is up, I don't know, 91% year to date still”
Open the episode · Synaptics Rises, Lumentum Falls, Acadia Pharma Jumps on Positive CHMP Drug OpinionListen at 2:49
The European CHMP gave Acadia's Rett syndrome drug a positive opinion.
“gave a positive opinion for its drug to treat symptoms of Rett syndrome”
Open the episode · Synaptics Rises, Lumentum Falls, Acadia Pharma Jumps on Positive CHMP Drug OpinionListen at 3:18
The positive CHMP opinion improves the drug's potential for European Union sales.
“positive update obviously as it relates to the potential for sales of this drug in the European Union”
Open the episode · Synaptics Rises, Lumentum Falls, Acadia Pharma Jumps on Positive CHMP Drug OpinionListen at 3:40
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
